Monoclonal antibody BR55-2

N/A

Report date: 2024/08/24 20:00:15

Base Information

Drug NameMonoclonal antibody BR55-2
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBracco Diagnostics Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Pancreatic Ductal

Other Information

ATC CodeN/A
Related LinksN/A